I-Mab Biopharma
IMAB
#8919
Rank
โ‚ฌ78.8 M
Marketcap
1,02ย โ‚ฌ
Share price
2.88%
Change (1 day)
-36.05%
Change (1 year)

Earnings for I-Mab Biopharma (IMAB)

Earnings in 2024 (TTM): -โ‚ฌ12.25 Million

According to I-Mab Biopharma's latest financial reports the company's current earnings are โ‚ฌ36.36 Million. In 2022 the company made an earning of -โ‚ฌ0.35 Billion, an increase over its 2021 earnings that were of -โ‚ฌ0.35 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for I-Mab Biopharma from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ12.25 Million
2022-โ‚ฌ0.35 Billion-0.81%
2021-โ‚ฌ0.35 Billion-593.63%
2020 โ‚ฌ70.46 M-135.78%
2019 -โ‚ฌ0.2 Billion266.31%
2018 -โ‚ฌ53.76 Million25.9%
2017-โ‚ฌ42.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ17.24 Million 74.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.24 Billion 2,248.23%๐Ÿ‡บ๐Ÿ‡ธ USA